Income Statement (NABRIVA/THERAPEUTICS)

Technical Analysis Historical Data Financials News & Analysis

NABRIVA/THERAPEUTICS NEWS

Nabriva Therapeutics (NASDAQ:NBRV) and Supernus Prescription drugs (NASDAQ:SUPN) Head to Head Survey By MarketBeat - 3 weeks ago

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) and Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) are both small-cap medical companies, but which is the better business? We will compa… [+6614 chars]...

Read more
Antibiotic Collaboration and Licensing Agreements Evaluation Document and Listing 2016-2025: Benchmark Offers Entered Into via the Global's Main Biopharma Corporations By Research - 2 weeks ago

Dublin, June 17, 2025 (GLOBE NEWSWIRE) -- The "Antibiotic Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering. This report contains a comprehensiv… [+11342 chars]...

Read more
Sophisticated Urinary Tract Infections Marketplace Set to Expertise Surprising Development All through the Forecast Duration (2025–2034) | DelveInsight By DelveInsight - 4 days ago

New York, USA, July 03, 2025 (GLOBE NEWSWIRE) -- Complicated Urinary Tract Infections Market Set to Experience Stunning Growth During the Forecast Period (20252034) | DelveInsight  The growth of the… [+27175 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		218.63 2.71
1.26%
CVX 		147.4 -0.97
-0.65%
CAT 		391.51 -6.35
-1.6%
INTC 		22 -0.49
-2.18%
MSFT 		497.72 -1.12
-0.22%
DIS 		123.16 -0.84
-0.68%
DOW 		27.48 -0.98
-3.44%
CSCO 		68.93 -0.44
-0.63%
GS 		710.93 -12.75
-1.76%